Inactive Instrument

Ekso Bionics Holdings Inc Share Price Deutsche Boerse AG

Equities

US2826441030

Advanced Medical Equipment & Technology

End-of-day quote Deutsche Boerse AG
- EUR - Intraday chart for Ekso Bionics Holdings Inc

Financials

Sales 2024 * 2.05Cr 1.88Cr 171.46Cr Sales 2025 * 2.81Cr 2.58Cr 234.8Cr Capitalization 2.49Cr 2.28Cr 208.02Cr
Net income 2024 * -90L -82.59L -75Cr Net income 2025 * -40L -36.71L -33Cr EV / Sales 2024 * 1.21 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.89 x
P/E ratio 2024 *
-2.66 x
P/E ratio 2025 *
-5.71 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.79%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 54 01/21/01
Director of Finance/CFO 50 01/17/01
Chief Operating Officer 52 -
Members of the board TitleAgeSince
Director/Board Member 56 25/21/25
Director/Board Member 69 29/20/29
Director/Board Member 39 11/18/11
More insiders
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
More about the company